Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Intranasal Ketamine in Treatment-Resistant Depression [NA]

View source ↗

Summary

Completed clinical trial investigating intranasal ketamine for treatment-resistant depression. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal ketamine (ketamine)

Snippet

Sponsor: James Murrough | Conditions: Major Depressive Disorder | NA | Status: COMPLETED | Results posted: 2017-02-08